Male hormonal contraception
- PMID: 15105800
- DOI: 10.1016/j.ajog.2004.01.057
Male hormonal contraception
Abstract
Male hormonal contraception, based on the suppression of both gonadotropins, follicle-stimulating hormone and luteinizing hormone, resulting in marked decrease in sperm production, is designed for couples in stable relationships where the male partner desires to assume family planning responsibilities using reversible methods. Two large scale, multicenter studies that used testosterone injections as the prototype male hormonal contraceptive demonstrated when azoospermia and/or very severe oligozoospermia were attained, contraceptive efficacy was equivalent to female hormonal methods. Current studies aim to find the androgen alone or androgen plus progestin preparations that are most efficacious, user friendly, and with least potential adverse effects. It is likely that injections or implants of androgens either alone or with progestins will become the first male hormonal contraceptive available within this decade. Further research and development include the use of selective androgen and/or progestin receptor modulators, nonpeptide GnRH antagonists, and agents with local actions on the testis for male contraception.
Similar articles
-
Male contraception.Best Pract Res Clin Obstet Gynaecol. 2002 Apr;16(2):193-203. doi: 10.1053/beog.2001.0270. Best Pract Res Clin Obstet Gynaecol. 2002. PMID: 12041962 Review.
-
[Male contraception in 1987].Rev Prat. 1987 Sep 21;37(38):2302-11. Rev Prat. 1987. PMID: 3310192 French.
-
Contraceptive efficacy of a depot progestin and androgen combination in men.J Clin Endocrinol Metab. 2003 Oct;88(10):4659-67. doi: 10.1210/jc.2003-030107. J Clin Endocrinol Metab. 2003. PMID: 14557437 Clinical Trial.
-
Predictors for partial suppression of spermatogenesis of hormonal male contraception.Asian J Androl. 2008 Sep;10(5):723-30. doi: 10.1111/j.1745-7262.2008.00432.x. Asian J Androl. 2008. PMID: 18645675 Clinical Trial.
-
Male contraception: a realistic option?Eur J Contracept Reprod Health Care. 2006 Jun;11(2):69-80. doi: 10.1080/13625180600699548. Eur J Contracept Reprod Health Care. 2006. PMID: 16854679 Review.
Cited by
-
Discovery and therapeutic promise of selective androgen receptor modulators.Mol Interv. 2005 Jun;5(3):173-88. doi: 10.1124/mi.5.3.7. Mol Interv. 2005. PMID: 15994457 Free PMC article. Review.
-
Daily Oral Administration of the Novel Androgen 11β-MNTDC Markedly Suppresses Serum Gonadotropins in Healthy Men.J Clin Endocrinol Metab. 2020 Mar 1;105(3):e835-47. doi: 10.1210/clinem/dgaa032. J Clin Endocrinol Metab. 2020. PMID: 31976519 Free PMC article. Clinical Trial.
-
Role of Antisperm Antibodies in Infertility, Pregnancy, and Potential forContraceptive and Antifertility Vaccine Designs: Research Progress and Pioneering Vision.Vaccines (Basel). 2019 Sep 16;7(3):116. doi: 10.3390/vaccines7030116. Vaccines (Basel). 2019. PMID: 31527552 Free PMC article. Review.
-
Hormonal approaches to male contraception.Curr Opin Urol. 2010 Nov;20(6):520-4. doi: 10.1097/MOU.0b013e32833f1b4a. Curr Opin Urol. 2010. PMID: 20808223 Free PMC article. Review.
-
Does ethnicity matter in male hormonal contraceptive efficacy?Asian J Androl. 2011 Jul;13(4):579-84. doi: 10.1038/aja.2010.133. Epub 2011 Feb 14. Asian J Androl. 2011. PMID: 21317912 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources